BR100 Decreased By (-0.7%)
BR30 Decreased By (-0.77%)
KSE100 Decreased By (-0.53%)
KSE30 Decreased By (-0.55%)
BECO 5.66 Decreased By ▼ -0.02 (-0.35%)
BML 63.53 Decreased By ▼ -1.31 (-2.02%)
BOP 33.60 No Change ▼ 0.00 (0%)
CNERGY 8.14 Decreased By ▼ -0.10 (-1.21%)
DCL 11.40 Increased By ▲ 0.05 (0.44%)
FCCL 52.18 Decreased By ▼ -0.73 (-1.38%)
FCSC 5.52 No Change ▼ 0.00 (0%)
FFL 17.75 Decreased By ▼ -0.05 (-0.28%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.20 Decreased By ▼ -0.04 (-0.36%)
KEL 7.88 Decreased By ▼ -0.09 (-1.13%)
KOSM 5.63 Increased By ▲ 0.19 (3.49%)
MLCF 85.75 Decreased By ▼ -0.26 (-0.3%)
NBP 184.00 Decreased By ▼ -1.00 (-0.54%)
PACE 11.68 Decreased By ▼ -0.34 (-2.83%)
PAEL 40.30 Increased By ▲ 0.09 (0.22%)
PIAHCLA 25.87 Increased By ▲ 0.14 (0.54%)
PIBTL 17.05 Decreased By ▼ -0.27 (-1.56%)
PPL 224.70 Decreased By ▼ -0.60 (-0.27%)
PRL 34.60 Increased By ▲ 0.22 (0.64%)
PTC 64.19 Decreased By ▼ -1.27 (-1.94%)
SEARL 90.40 Decreased By ▼ -0.11 (-0.12%)
SSGC 26.56 Decreased By ▼ -0.20 (-0.75%)
TELE 9.08 Increased By ▲ 0.12 (1.34%)
THCCL 67.23 Decreased By ▼ -2.21 (-3.18%)
TPLP 11.40 Increased By ▲ 0.09 (0.8%)
TREET 24.70 Increased By ▲ 0.15 (0.61%)
TRG 71.14 Decreased By ▼ -0.53 (-0.74%)
WAVES 10.91 Decreased By ▼ -0.54 (-4.72%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)

A Letter of Understanding was signed here today between Ministry of National Health Services and Novartis for public private partnership to provide free treatment to poor cancer patients in Islamabad, Gilgit-Baltistan and Azad Kashmir. On this occasion, Special Assistant to Prime Minister on Health Dr Zafar Mirza said that cancer treatment is a priority of this government and public -private initiatives are encouraged. This is another step forward in providing relief to the masses in line with the concept of welfare state envisioned by Prime Minister.
He said all CNIC holders of Islamabad Capital Territory, Azad Kashmir and Gilgit-Baltistan could be enrolled in this project. The treatment Centers for this project will work at Pakistan Institute of Medical Sciences, Islamabad and Abbas Institute of Medical Sciences, Muzaffarabad, AJK. 100 percent free access for the patients of ICT, AJ&K and GB suffering from Blood Cancer (Chronic Myeloid leukemia/, Myelofibrosis and polycythemia Vera, Stomach Cancer, advance Kidney Cancer, Breast Cancer and Pancreatic cancer through a public private partnership between Federal Government and Novartis.
Dr Zafar Mirza said the Planning Commission has approved a PC-1, from 2019-2024, in which GoP will pay 10 percent cost of the project. This project has already been initiated by the provincial governments. Dr Zafar Mirza appreciated the support of Novartis.-PR

Copyright Business Recorder, 2019

Comments

Comments are closed for this article.